Frankfurt, Germany – October 28–30, 2025 – Huateng Pharma has announced its participation in CPHI Frankfurt 2025 and will exhibit at Stand 4.1H64. Following its presence at last year’s CPHI Milan, the company aims to reconnect with industry attendees and expand its global ...Learn More

Hunan Huateng Pharmaceutical Co., Ltd. (“Huateng Pharma”) is pleased to announce the offering of 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS No. 5952-92-1), a critical intermediate in the patented process to prepare Aficamten (CK-274). Aficamten is an investigational oral ...Learn More

When it comes to sun care, not all UV filters are created equal. While many people focus on SPF values (which mainly measure UVB protection), the truth is that UVA rays—the ones responsible for photoaging, pigmentation, and long-term skin damage—can be just as harmful. This is ...Learn More

Changsha, China – July 31, 2025 — Hunan Huateng Pharmaceutical Co., Ltd. is excited to announce the availability of three high-quality cosmetic ingredients now in stock and ready for immediate delivery. These trusted actives are ideal for formulations in skin brightening, ...Learn More

Changsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and pharmaceutical ...Learn More